# Clinical Benefits and Safety of Combined Polynucleotides and Hyaluronic Acid - Newest - for Acne Scars Treatment

> **NCT05936437** · NA · COMPLETED · sponsor: **Mastelli S.r.l** · enrollment: 30 (actual)

## Conditions studied

- Atrophic Scar

## Interventions

- **DEVICE:** Subjects treated with Newest medical device

## Key facts

- **NCT ID:** NCT05936437
- **Lead sponsor:** Mastelli S.r.l
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-16
- **Primary completion:** 2025-07-24
- **Final completion:** 2025-07-24
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05936437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05936437, "Clinical Benefits and Safety of Combined Polynucleotides and Hyaluronic Acid - Newest - for Acne Scars Treatment". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05936437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*